Retinal anti-VEGF treatment now, and what next? From loading doses to long-game thinking
1. Anti-vascular endothelial growth factor (anti-VEGF) therapy has changed the treatment of retinal diseases more than any other medical advance in modern retina practice [1]. In neovascular age-re...
Authors
- Georgios D. Panos (ORCID: https://orcid.org/0000-0001-8399-7456)
- W A Amoaku
- Iordanis Vagiakis
- Anastasios G. Konstas
- Theodoros Empeslidis
Institutions
- University of Nottingham (GB)
- Aristotle University of Thessaloniki (GR)
- He Eye Hospital (CN)
Publication Details
- Journal
- Expert Opinion on Pharmacotherapy
- Published
- 2026-06-24
- DOI
- https://doi.org/10.1080/14656566.2026.2695091
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00